CRISIL Limited has reaffirmed credit rating on the bank facilities of
Aarti Drugs Limited. The credit rating agency has reaffirmed the company’s long-term rating of Rs1,636cr at CRISIL AA- with a Stable outlook. The short-term rating has been reaffirmed at CRISIL A1+.
At around 1.49 pm, Aarti Drugs Ltd was trading at Rs716.55 per piece down by Rs2.6 or 0.36% from its previous closing of Rs719.15 per piece on the BSE.
The scrip opened at Rs729 and has touched a high and low of Rs729 and Rs716 respectively during intraday trade on Tuesday.
Related Tags: